By Dr. Paul Ehrlich
Last week the AAAAI and the ACAAI told allergists that there would be ample supplies of life-saving extracts for hymenoptera allergy shots. It stings to say this but today another bulletin went out.
Working to Address Costs and Availability
The AAAAI and ACAAI recognize that there are growing concerns among our members regarding venom immunotherapy related to recently announced changes. Among these is the lack of availability of venom extracts for allergists in Canada that could have an impact on availability of this critical therapy for Canadian patients. In addition, we are aware that there are selected shortages of venom in certain areas of the United States. Finally, cost increases in venom extracts appear to be on the horizon.
Both organizations are actively working on various approaches to address all three issues noted above. We are focused on insuring that life saving therapy for patients with venom hypersensitivity remains readily available and affordable for the patients we serve. We will continue to keep you updated on this situation.
Spring is coming. Be careful out there.